|
 |
 |
|
|
| { | Case Studies |
| { | Client Releases |
|
|
|
||||||||||||
|
|
|
|
|
|
|
||||||||
|
|
|
||||||||||||
 |
 |
|
|||||||||||||||||||||||||||||||||
|
|
|
|
NeoTropiX NeoTropiX is an early stage drug discovery company, based in Gaithersburg, Maryland, dedicated to the research, development and commercialization of virus-based therapies for the treatment of cancer. NeoTropiX conducts virotherapy research under a licensing agreement with Novartis. Founded in 2003, NeoTropiX has expanded on groundbreaking work conducted by some of the nation's leading cancer researchers at top global biotechnology companies. Using proprietary products, NeoTropiX is focusing its R&D efforts on the most promising cancer research, including treatment for neural tumors. For more information, please visit www.neotropix.com. << Go back to client list |
|||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||
